financetom
Business
financetom
/
Business
/
UAE says ADNOC vessel attacked in Hormuz, vows to defend navigation rights
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UAE says ADNOC vessel attacked in Hormuz, vows to defend navigation rights
Aug 15, 2026 2:39 AM

CAIRO, Aug 15 (Reuters) - UAE's Abu Dhabi National Oil

Company said on Saturday that one of its vessels came under

attack while transiting the Strait of Hormuz a day earlier, the

Emirati state news agency WAM reported.

The state oil company said no injuries were reported, with

the situation now under control, according to WAM.

Anwar Gargash, diplomatic adviser to the UAE president, said

Abu Dhabi would defend its sovereignty and interests, after

repeated attacks on ADNOC tankers.

"We will safeguard our rights to freedom of navigation ...

while continuing the path of dialogue and prioritising

diplomatic options," Gargash said in a post on X.

The attack was the third such incident involving ADNOC

vessels in less than a week. The UAE had accused Iran of being

behind the earlier attacks, but there was no official comment

from the UAE on Friday's attack.

The United Kingdom Maritime Trade Operations agency said

earlier it had received a report of a bulk carrier being struck

by an unknown projectile in the strait on Friday.

About a fifth of the world's oil and liquefied natural gas

passed through the narrow waterway between Oman and Iran before

the conflict. Since the U.S.-Israeli war with Iran broke out on

​February 28, shipping has ​been repeatedly disrupted, ⁠raising

freight rates and creating security concerns.

ADNOC ​is one of the world's largest energy producers and

exports crude oil, natural gas and refined products ​worldwide.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia Tops Third-Quarter Estimates on Strong AI Demand
Nvidia Tops Third-Quarter Estimates on Strong AI Demand
Nov 19, 2025
04:55 PM EST, 11/19/2025 (MT Newswires) -- Nvidia ( NVDA ) reported fiscal third-quarter results that surpassed Wall Street's estimates as the chipmaker continued to benefit from rising demand for artificial intelligence. The technology bellwether's adjusted per-share earnings in the three months ended Oct. 26 increased to $1.30 from $0.81 a year earlier. That topped the consensus on FactSet of...
Properly Investment Boosts Stake in Swiss Water Decaffeinated Coffee to 13.8%
Properly Investment Boosts Stake in Swiss Water Decaffeinated Coffee to 13.8%
Nov 19, 2025
04:54 PM EST, 11/19/2025 (MT Newswires) -- Properly Investment (SWP.TO) after trade Wednesday said it bought 6,791 shares of Swiss Water Decaffeinated Coffee ( SWSSF ) on the Toronto Stock Exchange for about $30,239. Before this purchase, the company owned 1,310,700 shares, or 13.73%. After the transaction, it now holds 1,317,491 shares, or 13.80% of the company, according to the...
Yann LeCun to leave Meta, launch AI startup focused on Advanced Machine Intelligence
Yann LeCun to leave Meta, launch AI startup focused on Advanced Machine Intelligence
Nov 19, 2025
(Reuters) -Yann LeCun, one of the founding figures of modern artificial intelligence and a pivotal force at Meta Platforms ( META ), said on Wednesday he plans to leave the company at the end of the year to launch a new AI startup. LeCun has been a key part of Meta's artificial intelligence ambitions for more than a decade. He...
Amgen Says FDA Granted Full Approval to Imdelltra to Treat Extensive Stage Small Cell Lung Cancer
Amgen Says FDA Granted Full Approval to Imdelltra to Treat Extensive Stage Small Cell Lung Cancer
Nov 19, 2025
04:52 PM EST, 11/19/2025 (MT Newswires) -- Amgen ( AMGN ) said Wednesday the US Food and Drug Administration has given full approval to Imdelltra, or tarlatamab-dlle, to treat adults with extensive stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The company said the FDA's decision to convert Imdelltra's previous accelerated approval to a full...
Copyright 2023-2026 - www.financetom.com All Rights Reserved